Hypoglycemia News and Research

RSS

Hypoglycemia, also called low blood glucose or low blood sugar, occurs when blood glucose drops below normal levels. Glucose, an important source of energy for the body, comes from food. Carbohydrates are the main dietary source of glucose.

Automated insulin delivery systems: Advancements and future prospects

A special 13-article supplement to the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) examines the "Development and Future of Automated Insulin Delivery (AID) Systems.

23 Feb 2024

New position statement emphasizes patient-centered care in diabetes management

Health care providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person's glucose goals.

21 Feb 2024

Study reveals gaps in emergency medical services performance, suggests room for improvement

Study evaluates EMS performance across the U.S., revealing significant variability in care quality and identifying areas for improvement based on national data.

18 Feb 2024

States target health insurers’ ‘prior authorization’ red tape

Christopher Marks noticed an immediate improvement when his doctor prescribed him the Type 2 diabetes medication Mounjaro last year.

12 Feb 2024

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

AMG 133, an engineered bispecific molecule, demonstrated significant weight loss with a favorable safety profile in a phase 1 clinical trial, offering a promising new treatment option for obesity.

7 Feb 2024

Comparing perioperative differences: Sleeve gastrectomy vs. Roux-en-Y gastric bypass

Study compares laparoscopic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in obese patients, finding both procedures have low, comparable perioperative risks and complications, challenging the criteria for selecting between the two surgeries.

1 Feb 2024

New oral insulin delivered via nano-carriers could soon replace injections

There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily.

19 Jan 2024

Heart-healthy diet boosts patient satisfaction and safety before cardiac catheterization

The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of evidence grows to allow patients to eat before the procedure.

3 Jan 2024

Postpartum phagocytosis of pancreatic β-cells by macrophages regulates blood glucose levels

Pancreatic beta cells (β-cells) reside in a cluster of cells in the pancreas known as the islets of Langerhans.

4 Dec 2023

Beyond insulin: Medi-Cal expands patient access to diabetes supplies

June Voros sprang from her couch as a high-pitched beep warned her that she needed a quick dose of sugar.

17 Nov 2023

UK regulator approves a diabetes drug for weight management in obese and overweight patients

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (8 November 2023) authorised via a national application route, a new indication for the diabetes medicine, Mounjaro (tirzepatide), for weight loss and weight management in adults aged 18 and over.

13 Nov 2023

Time-restricted eating outperforms calorie counting in weight loss for type 2 diabetes patients

In a six-month randomized clinical trial, researchers found that time-restricted eating (TRE) was more effective than daily calorie restriction for weight loss and equally effective in regulating glucose levels in adults with type 2 diabetes. The study suggests TRE could be a simpler and more easily adhered to dietary strategy for managing the condition.

31 Oct 2023

Time-restricted eating helps people with type 2 diabetes lose weight and control blood sugar

Time-restricted eating, also known as intermittent fasting, can help people with Type 2 diabetes lose weight and control their blood sugar levels, according to a new study published in JAMA Network Open from researchers at the University of Illinois Chicago.

27 Oct 2023

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

New orally-administered GLP-1 receptor agonists danuglipron and orforglipron show promise in treating type 2 diabetes and obesity, according to a systematic review. While effective in glycemic control and weight reduction, these drugs come with gastrointestinal side effects that may lead to treatment discontinuation.

17 Oct 2023

Are migraines linked to gut health and chronic non-communicable diseases?

The Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).

13 Oct 2023

International report paves way for precision diabetes medicine breakthrough

Precision medicine for prevention, diagnosis, treatment, and prognosis for Diabetes.

9 Oct 2023

A telehealth model to support remote diabetes self-care

Researchers develop and test the effectiveness of a Virtual Diabetes Specialty Clinic (VDiSC), a virtual model facilitating comprehensive diabetes care remotely.

6 Oct 2023

Early metformin therapy falls short in curbing gestational diabetes woes

In a significant randomized clinical trial, early metformin therapy was tested for its potential to lessen insulin dependence and enhance glycemic control in gestational diabetes-afflicted pregnant women; however, it yielded no improvements in diabetes symptoms. While metformin reduced maternal weight gain, its effects on primary diabetes symptoms and other secondary outcomes like infant weight gain were mixed, indicating a need for further focused research to unravel these associations.

4 Oct 2023

Study finds link between food insecurity and severe hypoglycemia

New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found that severe hypoglycemia is more than twice as common among adults with diabetes who struggle to afford food.

3 Oct 2023

Tirzepatide outshines other treatments in lowering blood sugar and weight for type 2 diabetes patients

Meta-analysis finds tirzepatide to be the most effective GLP-1 receptor agonist for glucose and weight control in type 2 diabetes patients. The study suggests tirzepatide could be preferable in initial stages of the disease, while other GLP-1 receptor agonists combined with insulin are equally effective for long-term diabetics.

25 Sep 2023